Principle, strengths and weaknesses of discrete choice modelling for eliciting public preferences for health care

被引:12
作者
Berchi, C. [1 ]
Launoy, G. [1 ]
机构
[1] CHU Caen, Fac Med, ERI Inserm Canc & Populat 3, F-14032 Caen, France
来源
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE | 2007年 / 55卷 / 02期
关键词
health economics; preferences elicitation; discrete choice modelling;
D O I
10.1016/j.respe.2006.11.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Patients play an increasingly active role in the medical decision making process. Hence, methods for eliciting public preferences have become essential tools for enlightening the choices of health authorities. Discrete choice modelling is the most recently applied technique in the field of health. This article deals with the principle, the strengths and the weaknesses of this method. Often used in English-speaking countries, the discrete choice method has several advantages over other elicitation methods since it allows estimation of marginal utilities. Compliance rates are also higher and more information is provided. Considering these qualities, further research should be undertaken on discrete choice modelling in France. (C) 2007 Elsevier Masson SAS. Tons droits reserves.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 34 条
[1]  
[Anonymous], FRONTIERS ECONOMETRI
[2]  
BEGGS S, 1981, J ECONOMETRICS, V16, P1
[3]   COMMERCIAL USE OF CONJOINT-ANALYSIS - A SURVEY [J].
CATTIN, P ;
WITTINK, DR .
JOURNAL OF MARKETING, 1982, 46 (03) :44-53
[4]   EXPLOITING RANK ORDERED CHOICE SET DATA WITHIN THE STOCHASTIC UTILITY MODEL [J].
CHAPMAN, RG ;
STAELIN, R .
JOURNAL OF MARKETING RESEARCH, 1982, 19 (03) :288-301
[5]  
College des Economistes de la Sante (CES), 2003, GUID METH EV EC STRA
[6]  
Drakopoulos S., 1994, J ECON SURV, V8, P133, DOI DOI 10.1111/J.1467-6419.1994.TB00097.X
[7]  
Drummond M., 2015, METHODS EC EVALUATIO, V4
[8]   Using discrete choice modelling in priority setting: an application to clinical service developments [J].
Farrar, S ;
Ryan, M ;
Ross, D ;
Ludbrook, A .
SOCIAL SCIENCE & MEDICINE, 2000, 50 (01) :63-75
[9]  
Farrar S, 1999, HEALTH ECON, V8, P75, DOI 10.1002/(SICI)1099-1050(199902)8:1<75::AID-HEC400>3.0.CO
[10]  
2-5